Maa: Yhdistynyt kuningaskunta
Kieli: englanti
Lähde: MHRA (Medicines & Healthcare Products Regulatory Agency)
Cyclizine lactate
Advanz Pharma
R06AE03
Cyclizine lactate
50mg/1ml
Solution for injection
Intravenous; Intramuscular
No Controlled Drug Status
Valid as a prescribable product
BNF: 04060000; GTIN: 5060337260763
OBJECT 1 CYCLIZINE 50MG TABLETS Summary of Product Characteristics Updated 10-Apr-2015 | Concordia International - formerly AMCo 1. Name of the medicinal product Valoid 1 50 mg Tablets Cyclizine Hydrochloride 50 mg Tablets 2. Qualitative and quantitative composition Each tablet contains 50 mg of cyclizine hydrochloride. Excipient with known effect: Lactose. For a full list of excipients, see section 6.1. 3. Pharmaceutical form White, biconvex, uncoated tablet, scored; coded T4A. The scoreline is only to facilitate breaking for ease of swallowing and not to divide into equal doses 4. Clinical particulars 4.1 Therapeutic indications Cyclizine Hydrochloride is indicated in adults and in children aged 6 years and over for the prevention and treatment of nausea and vomiting including:- • Motion sickness. • Nausea and vomiting caused by narcotic analgesics and by general anaesthetics in the post-operative period. • Vomiting associated with radiotherapy, especially for breast cancer since cyclizine does not elevate prolactin levels. Cyclizine Hydrochloride may be of value in relieving vomiting and attacks of vertigo associated with Menière's disease and other forms of vestibular disturbance. 4.2 Posology and method of administration Posology To prevent motion sickness Cyclizine Hydrochloride should be taken about one to two hours before departure. OLDER PEOPLE There have been no specific studies of Cyclizine Hydrochloride in the elderly. Experience has indicated that normal adult dosage is appropriate. PAEDIATRIC POPULATION Children less than 6 years of age: Cyclizine Hydrochloride tablets are not recommended for children less than 6 years of age. Children 6 to 12 years of age: 25 mg orally, which may be repeated up to three times a day. Children over 12 years of age: 50 mg orally, which may be repeated up to three times a day. Adults 50 mg orally, which may be repeated up to three times a day. Method of administration: Oral 4.3 Contraindications Hypersensitivity to the active substance or to any of the excipient Lue koko asiakirja